Average Co-Inventor Count = 5.03
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (23 from 2,405 patents)
2. Amgen Inc. (6 from 1,975 patents)
3. The University of Texas System (4 from 5,469 patents)
4. Other (1 from 832,880 patents)
5. Merck Sharpe & Dohme Corp. (1 from 35 patents)
34 patents:
1. 11713313 - GLS1 inhibitors for treating disease
2. 11690850 - Inhibitors of receptor interacting protein kinase I for the treatment of disease
3. 10738043 - GLS1 inhibitors for treating disease
4. 10125128 - GLS1 inhibitors for treating disease
5. 9115127 - Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinase
6. 9096615 - Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta-secretase and methods of use thereof
7. 9066954 - Fused heterocyclic derivatives and methods of use
8. 8716281 - Pyrimidine compounds that inhibit anaplastic lymphoma kinase
9. 8524900 - Fused heterocyclic derivatives and methods of use
10. 8198448 - Fused heterocyclic derivatives and methods of use
11. 8163956 - Inhibitors of GLYT1 transporters
12. 7851638 - Cyclohexanesulfonyl derivatives as GLYT1 inhibitors to treat schizophrenia
13. 7825135 - Heteroaryl piperidine glycine transporter inhibitors
14. 7655644 - Piperidine and azetidine derivatives as GlyT1 inhibitors
15. 7626056 - Cyclohexanesulfonyl derivatives as GlyT1 inhibitors to treat schizophrenia